McGlone Suttner Wealth Management Inc. increased its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 4.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 16,869 shares of the financial services provider’s stock after purchasing an additional 750 shares during the quarter. McGlone Suttner Wealth Management Inc.’s holdings in MetLife were worth $1,381,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. MeadowBrook Investment Advisors LLC raised its holdings in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its stake in MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC grew its holdings in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares during the period. Peterson Financial Group Inc. purchased a new position in MetLife during the third quarter worth approximately $30,000. Finally, Retirement Wealth Solutions LLC acquired a new position in shares of MetLife in the 4th quarter valued at $32,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Price Performance
MET opened at $86.82 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company’s 50-day moving average price is $83.68 and its 200 day moving average price is $79.82. MetLife, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $89.05. The firm has a market cap of $60.11 billion, a price-to-earnings ratio of 17.50, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07.
MetLife Announces Dividend
Wall Street Analysts Forecast Growth
MET has been the topic of several research reports. BMO Capital Markets initiated coverage on MetLife in a research report on Thursday. They issued a “market perform” rating and a $97.00 target price on the stock. StockNews.com lowered MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Piper Sandler raised their target price on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Barclays boosted their target price on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. lifted their price target on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 7th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, MetLife currently has an average rating of “Moderate Buy” and a consensus target price of $90.46.
View Our Latest Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Stock Market Upgrades: What Are They?
- Despite Short-Term Risks Freeport McMoran Worth a Look
- Stock Sentiment Analysis: How it Works
- 3 Lean and Mean Stocks Generating Over $1M in Revenue Per Worker
- Earnings Per Share Calculator: How to Calculate EPS
- The Next Big Thing in AI: 2 Edge Computing Chipmakers to Watch
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.